Literature DB >> 11359572

Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene.

R Deora1, H J Bootsma, J F Miller, P A Cotter.   

Abstract

The BvgAS signal transduction system controls the expression of at least three distinct phenotypic phases that lie along a continuum of gene expression states. The Bvg+ phase is characterized by the expression of adhesins and toxins, whereas the Bvg- phase is characterized by motility in Bordetella bronchiseptica and the expression of vrg loci in Bordetella pertussis. The Bvg-intermediate (Bvgi) phase is characterized by the absence of Bvg-repressed phenotypes, the expression of some, but not all, Bvg-activated virulence factors and the presence of a recently discovered set of antigens and phenotypes that are unique to this phase. We report here the transcriptional regulation of bipA, the first-identified Bvgi phase gene. We have mapped the bipA promoter and identified numerous BvgA binding sites in the transcriptional control region. Based on these data, we present a model in which phase-dependent expression of bipA results from the spatial distribution and relative affinities of multiple BvgA binding sites relative to the start site of transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359572     DOI: 10.1046/j.1365-2958.2001.02415.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  46 in total

1.  Analysis of bvgR expression in Bordetella pertussis.

Authors:  Tod J Merkel; Philip E Boucher; Scott Stibitz; Vanessa K Grippe
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

2.  Activation of the vrg6 promoter of Bordetella pertussis by RisA.

Authors:  Tadhg O Cróinín; Vanessa K Grippe; Tod J Merkel
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

3.  Mode of action of the Bordetella BvgA protein: transcriptional activation and repression of the Bordetella bronchiseptica bipA promoter.

Authors:  Meenu Mishra; Rajendar Deora
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli.

Authors:  M Chelsea Lane; Amy N Simms; Harry L T Mobley
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

6.  Target genes and DNA-binding sites of the response regulator PhoR from Corynebacterium glutamicum.

Authors:  Sarah Schaaf; Michael Bott
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

7.  Organization and PprB-dependent control of the Pseudomonas aeruginosa tad Locus, involved in Flp pilus biology.

Authors:  Christophe S Bernard; Christophe Bordi; Elise Termine; Alain Filloux; Sophie de Bentzmann
Journal:  J Bacteriol       Date:  2009-01-16       Impact factor: 3.490

8.  Structural insight into the role of the PAS domainfor signal transduction in sensor-kinase BvgS.

Authors:  Elian Dupré; Bernard Clantin; Youhua Yuan; Sophie Lecher; Elodie Lesne; Rudy Antoine; Vincent Villeret; Françoise Jacob-Dubuisson
Journal:  J Bacteriol       Date:  2021-02-22       Impact factor: 3.490

9.  The Escherichia coli BarA-UvrY two-component system is needed for efficient switching between glycolytic and gluconeogenic carbon sources.

Authors:  Anna-Karin Pernestig; Dimitris Georgellis; Tony Romeo; Kazushi Suzuki; Henrik Tomenius; Staffan Normark; Ojar Melefors
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

10.  Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella.

Authors:  Julien Herrou; Anne-Sophie Debrie; Eve Willery; Geneviève Renauld-Mongénie; Geneviève Renaud-Mongénie; Camille Locht; Frits Mooi; Françoise Jacob-Dubuisson; Rudy Antoine
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.